Revenue (Tables)

9 Months Ended

Jun. 30, 2021

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
(In thousands)	2021		2020		2021		2020
Medical Device
Product sales	$	5,493	$	5,763	$	15,464	$	16,240
Royalties		7,752		4,752		23,135		20,365
Research, development and other		2,466		2,353		7,212		7,215
License fees		1,044		7,646		15,047		10,402
Total Revenue — Medical Device		16,755		20,514		60,858		54,222
In Vitro Diagnostics
Product sales		6,591		6,224		18,505		17,491
Research, development and other		527		145		1,802		608
Total Revenue — In Vitro Diagnostics		7,118		6,369		20,307		18,099
Total Revenue	$	23,873	$	26,883	$	81,165	$	72,321